Bruker Corporation Secures $500 Million Superconductor Supply Agreements
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 13h ago
0mins
Source: Newsfilter
- Supply Agreement Expansion: Bruker's Energy & Supercon Technologies division has signed two multi-year supply agreements with global radiology companies, with an expected future revenue of approximately $500 million, further solidifying its leadership in the MRI magnet market.
- Diverse Agreement Durations: One of the agreements extends up to seven years, which not only ensures a long-term revenue stream but also enhances Bruker's competitive position in the superconducting materials sector.
- High-Performance Superconductors: Under the new agreements, Bruker will supply high-performance superconductors to MRI magnet production sites in the U.S. and the U.K., meeting stringent performance and quality requirements, thereby improving customer satisfaction and technological leadership.
- Market-Driven Innovation: Bruker's superconductors support new helium-free MRI magnet architectures, reducing costs and enhancing sustainability, which further drives growth potential in the MRI market.
Analyst Views on BRKR
Wall Street analysts forecast BRKR stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BRKR is 44.60 USD with a low forecast of 42.00 USD and a high forecast of 50.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
4 Buy
3 Hold
0 Sell
Moderate Buy
Current: 52.480
Low
42.00
Averages
44.60
High
50.00
Current: 52.480
Low
42.00
Averages
44.60
High
50.00
About BRKR
Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





